CALIBER - A phase II randomised feasibility trial of chemoablation with mitomycin versus surgical management in low risk non-muscle invasive bladder cancer

Mostafid, A.H., Porta, N., Cresswell, J. et al. (14 more authors) (2020) CALIBER - A phase II randomised feasibility trial of chemoablation with mitomycin versus surgical management in low risk non-muscle invasive bladder cancer. BJU International. ISSN 1464-4096

Abstract

Metadata

Authors/Creators:
  • Mostafid, A.H.
  • Porta, N.
  • Cresswell, J.
  • Griffiths, T.R.L.
  • Kelly, J.D.
  • Penegar, S.R.
  • Davenport, K.
  • McGrath, J.S.
  • Campain, N.
  • Cooke, P.
  • Masood, S.
  • Knowles, M.A.
  • Feber, A.
  • Knight, A.
  • Catto, J.W.F. https://orcid.org/0000-0003-2787-8828
  • Lewis, R.
  • Hall, E.
Copyright, Publisher and Additional Information: © 2020 The Authors BJU International © 2020 BJU International. This is an author-produced version of a paper subsequently published in BJU International. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: non‐muscle invasive bladder cancer; chemoablation; surgery; mitomycin C; randomised trial
Dates:
  • Published (online): 3 March 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 13 Mar 2020 12:09
Last Modified: 13 Mar 2020 12:10
Status: Published online
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1111/bju.15038
Related URLs:

Download

Accepted Version


Embargoed until: 3 March 2021

Filename: Mostafid_et_al-2020-BJU_International.pdf

Request a copy

Share / Export

Statistics